NGB Innovation Program
Bold science. Rigorous review.
We look for early-stage science that could change human health, and we test it hard before we back it.
The Innovation Program is a program of NGBiologics Institute. Not a separate company, fund, or subsidiary.
Where we look
The fields where breakthroughs matter most.
Healthy Aging and Longevity
Extending the years people live in good health.
Regenerative Biology and Medicine
Restoring what age and disease take away.
Neuroscience
Protecting the brain across a longer life.
Metabolic Health
Intervening before chronic disease sets in.
Immunology and Oncology
Immune decline and cancer, treated as one problem.
Precision Diagnostics
Measuring what matters, earlier.
How we support
Two ways we move science forward.
Research Grants
Non-dilutive funding for the work that proves an idea: validation, proof of concept, independent testing, real data. Awarded on merit. We take no ownership.
Mission-Aligned Investment
Where capital is what moves the science forward, we can invest. The mission is the purpose. Financial return is never the reason.
How we decide
Science clears first. Terms come second.
Discover
We find it, or you bring it.
Screen
Does it fit the mission?
Scientific Review
Is the science credible?
Diligence
Structure, risk, conflicts.
Decision
Documented, with reasons.
The committee that judges the science does not negotiate the deal. Nothing reaches terms that has not already cleared scientific and ethical review.
What we look for
Four questions we ask every time.
Is the science real?
Credible evidence, appropriate to its stage.
Does it matter?
A meaningful unmet need in human health.
Can they execute?
A realistic path, and the capability to walk it.
Who does it help?
Broad, lasting public benefit.
Submissions
Submissions open against published standards.
Submissions open against published standards, not a private process. Every applicant receives a documented decision with reasons, including those we decline.